Fabrice Leboeuf

Title: Fabrice Leboeuf: Innovator in Virus-Derived Particle Technology

Introduction

Fabrice Leboeuf is a notable inventor based in Gatineau, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of non-replicating virus-derived particles. His innovative work has the potential to impact various applications in medicine and research.

Latest Patents

Fabrice holds a patent for "Non-replicating virus-derived particles and uses thereof." This patent describes a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells while exhibiting tropism against immortalized cells. The particle may also possess cytolytic tropism against these cells. Additionally, it is noted that the particle has innate and/or adaptive immune-stimulating properties, making it a valuable asset in therapeutic applications.

Career Highlights

Fabrice is currently associated with Celverum Inc., where he continues to advance his research and development efforts. His work at the company focuses on harnessing the unique properties of virus-derived particles for innovative solutions in the biomedical field.

Collaborations

Fabrice collaborates with talented individuals such as David Conrad and Cory Batenchuk. Their combined expertise fosters a dynamic environment for innovation and discovery.

Conclusion

Fabrice Leboeuf's contributions to the field of biotechnology through his patent on non-replicating virus-derived particles highlight his role as an influential inventor. His work at Celverum Inc. and collaborations with colleagues further emphasize his commitment to advancing scientific knowledge and applications.